Inhalation Sciences Sweden AB

📍 Flemingsberg, Sweden🗓 Founded 2005👥 13 employees💰 Last funded May 2017
We believe in excellence, and we measure it by results. Our clients know that our dry powder aerosol generating platform, PreciseInhale, delivers regional lung data of a quality far beyond other inhalation technologies. PreciseInhale lets them carry out a full PK study using just 50-100 mg of test substance delvering results with a typical standard deviation of <10%.SD. Our in vitro capabilities are widely recognized as world-leading, bringing clients closer than ever to full IVIVC. PreciseInhale can include a series of exposure modules (from in vitro through to in vivo to clinical.) It can generate respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, providing a translational ladder for inhalation R&D programs. Visit our website: http://www.inhalation.se/ Visit our labs: We welcome visitors to our labs in Stockholm, Sweden Kliniskt Forskningscentrum KFC Novum plan 6 hiss A Hälsovägen 7 141 57 Huddinge, Sweden Visitor entrance, Blickagången 6, elevator E, level 6
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2005
Founded
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Inhalation Sciences Sweden AB?
Inhalation Sciences Sweden AB has 2 investors on record on gritt.io.
When did Inhalation Sciences Sweden AB last raise funding?
The most recent investment in Inhalation Sciences Sweden AB recorded on gritt.io was in May 2017.
When was Inhalation Sciences Sweden AB founded?
Inhalation Sciences Sweden AB was founded in 2005.
What industry is Inhalation Sciences Sweden AB in?
Inhalation Sciences Sweden AB operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Inhalation Sciences Sweden AB based?
Inhalation Sciences Sweden AB is headquartered in Flemingsberg, Sweden.